Revive Therapeutics Ltd. (RVV)

Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.

Market Performance

News & Interviews

Revive Therapeutics Press Release
Press Release

Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

June 30, 2020
Read More →
Revive Therapeutics Press Release
Press Release

Revive Therapeutics Expands Research Partnership for Novel Formulation Development and Clinical Research of Psilocybin with the University of Wisconsin-Madison

June 12, 2020
Read More →
Revive Therapeutics Press Release
Press Release

Revive Therapeutics Provides Update on Discussions with Health Canada in Pre-CTA Meeting

June 9, 2020
Read More →

Financials

Note: due to the emergent nature of the psychedelics sector, many publicly listed companies do not have complete valuation or financial data.